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Introduction
Gene therapy is still in its infancy, but it offers a unique approach to treat disease by providing appropriate materials for curing or alleviating both inherited and acquired disorders. 1 Many transfer methods are being explored as a means to effect human gene therapy, either in vitro in model systems, or in vivo. 1, 2 The ideal aimed for is a method that achieves high-level, nontoxic, longterm expression of a delivered gene, a goal not yet reached in practice. Nonviral techniques are better for transient than long-term expression; however, they have desirable properties in that they neither introduce unwanted genetic information into cells nor elicit immune responses. Thus, these methods are suitable for repeated use. 3 Mammalian viral vectors have been widely assessed, exploiting the specialised mechanisms viruses have evolved to target cells and express genes.
into the host chromosomes, have been evaluated particularly extensively; however, gene transfer is only efficient in actively dividing cells. 4, 6, 7 Adenoviruses have also evoked much interest as vector systems but recognition of viral genes by the host immune system poses a major problem not yet wholly overcome. 8, 9 A serious disadvantage shared by all the present viral vectors is that they introduce undesirable genetic information into recipient cells.
An alternative approach using assembled particles (pseudocapsids) formed from the major capsid protein, VP1, of mouse polyoma virus overcomes many of the drawbacks of current vectors. VP1, generated from a recombinant baculovirus, has been shown not only to self-assemble, but to be competent for entering many cell types, and to target the nucleus. 10 VP1 pseudocapsids have been used to transfer a reporter plasmid carrying the chloramphenicol acetyltransferase (CAT) gene into human CCL 13 liver cells, or a transforming oncogene into rodent cells in culture, 10 by a process we now call pseudofection. There is, however, an apparent size limitation of exogenous naked DNA, about 3 kbp, that can be complexed with pseudocapsids in vitro in such a way as to be protected against DNase activity, although up to 5 kbp of DNA, complexed with histones, can be packaged. 11 Unprotected DNA would presumably be subject to intracellular degradation, accounting for the fact that in transfection experiments, 'naked' DNA is generally only suitable for transient expression, and then only in vivo. 1 To overcome the apparent limited DNA size capacity of pseudocapsid carriers, and protect nonpackaged DNA from degradation during its route through the cell, as well as to condense the complexes, we explored the use of the polycationic amine, poly-l-lysine (polylysine), for accomplishing these aims. Polylysine has been successfully used both in receptor-mediated gene transfer and as a means of linking heterologous DNA to specific targeting ligands for other receptor-mediated approaches in gene transfer experiments. 12, 13 An electrostatic interaction between the negatively charged DNA and the positively charged polymer serves not only to bind the DNA to ligands but also to condense it into a compact structure. 14 Polylysine has also been used together with adenovirus vectors to enhance efficiency of uptake of the latter. 15 Our studies show that polylysine, added to the DNA/pseudocapsid transfer system, augments shortterm delivery of gene activity to cells, including human, in vitro, and has similar effects in in vivo experiments. Its presence is not, however, mandatory for transferring higher molecular weight DNAs by pseudocapsids, and may even be of negative value for long-term gene expression. Transgene expression in vivo by pseudocapsid routes was sustained for several months without detectable pathology, with some differences observed with regard to targeted organs when polylysine was present. Thus, whereas polylysine per se alters the ability of VP1 pseudocapsids to enter cells specifically and enhances transient expression, it may be of limited value for long-term expression of exogenous genes.
Results
Protection of exogenous DNA with polylysine The major polyoma viral capsid antigen, VP1, selfassembled into pseudocapsids, has the ability to bind DNA nonspecifically in a cell-free system. In early studies, the size of exogenous DNA found in association with pseudocapsid particles and protected from low level copurifying cellular DNaseI activity, was found to be about 3 kbp. 10 We have subsequently modified the purification protocol of VP1 in such a way as to remove accompanying DNaseI activities from particles (see Materials and methods). To explore the efficiency of transfer of larger DNAs, we tested whether polylysine could interact with DNA-pseudocapsid complexes, then measured the degree of protection it might afford against the action of extracellular DNases introduced in in vitro experiments to a 7.2 kbp mixture of supercoiled and open circular plasmid DNA (pCMV␤). Digestion of plasmid DNA by DNaseI at 37°C for l h in DNA-pseudocapsid complexes, with or without added polylysine, was analysed by gel electrophoresis. The results (Figure 1) show that whereas unprotected DNA, shown in lane 2, was completely degraded by the enzyme activity (lane 3), and most of the DNA packaged with pseudocapsids without polylysine protection was digested to products ranging between 2 and 3 kbp in size (lane 4), consistent with earl- ier work, 10 more than 50% of the full-length DNA mixed with polylysine (lanes 5-7) was protected from degradation. Similar results were obtained when polylysine was added to DNA in the absence of capsids (lane 7), or to pre-formed DNA-pseudocapsid complexes (lane 5) or when capsids were added to pre-formed DNApolylysine complexes (lane 6). The data suggest that polylysine per se can efficiently protect DNA from enzymic digestion.
Structural alterations influenced by the mode of complex formation Following packaging, interactions of either DNApseudocapsids, DNA-polylysine, or mixtures of all three (DNA-polylysine-pseudocapsids) were analysed by observing the density of complexes by CsCl equilibrum centrifugation (Figure 2a-d, respectively) . Complexes with pCMV␤ (7.2 kbp) DNA were sedimented on CsCl gradients and the location of pseudocapsids detected following measurement of refractive indices and identification of peak VP1 fractions by SDS-PAGE. An aliquot of each fraction was transferred on to filters by slot blotting and the DNA identified by hybridisation with 32 P randomly labelled linearised pCMV␤ DNA. The strength of the signal in each fraction was determined by densitometric analysis of the resulting autoradiograms. Uncomplexed DNA sedimented at the bottom of the CsCl gradient, whilst DNA complexed with polylysine only (peak refractive index 1.372, Figure 2b ) was observed in fractions between those containing DNA only and complexes with pseudocapsids (peak refractive index 1.361, Figure 2a ). Whereas Ͼ50% of the DNA was found in association with pseudocapsids either in the absence of polylysine (Figure 2a ), or when polylysine was added to pre-formed DNA-pseudocapsid complexes (Figure 2c ), DNA bound first with polylysine, followed by addition of pseudocapsids (Figure 2d ), showed little (Ͻ5%) comigration with pseudocapsids.
As pCMV␤ DNA mixed with polylysine before treatment with pseudocapsids appeared to form different structures from those observed when the mixing protocol was reversed, complexes were further studied by electron microscopy (EM) (Figure 3 ). The reaction mixture of pCMV␤ DNA and pseudocapsids after packaging ( Figure  3a ) contained complexes consisting of two, three or four particles per DNA molecule; in the presence of polylysine alone (Figure 3b ), profound condensation of DNA occurred. DNA-pseudocapsid complexes were further condensed as a result of subsequent addition of polylysine (Figure 3c ). However, pseudocapsids mixed with DNA-polylysine complexes produced gross aggregation with many molecules of DNA and capsids combining with polylysine ( Figure 3d ). If structural alterations can influence uptake by cells, the considerable bulk of some of the complexes, such as seen (Figure 3b and d), might be expected to inhibit transfer of materials into cellsparticularly if uptake is receptor mediated -and subsequently to the nucleus for long-term gene expression. 16 Although different mixing procedures were explored in data shown in Figures 1-3 , as part of the aim of this work was to assess the role of pseudocapsids in gene transfer, ternary complexes were subsequently generated by adding polylysine to pre-formed DNA-pseudocapsid complexes, since it was not obvious that pseudocapsids bound DNA pre-complexed with polylysine.
Influence of concentrations of polylysine and Ca
2+ ions on pseudofection efficiency We further explored whether varying the ratios between DNA-pseudocapsid complexes and polylysine might also alter structure, and influence the efficiency of pseudofection. To establish an optimal ratio of DNApseudocapsid complexes and polylysine for reactions, constant amounts of plasmid DNA encoding the ␤-galactosidase gene (pCMV␤), or DNA-pseudocapsids, were mixed with increasing amounts of polylysine and mixtures were incubated with 4 × 10 5 (half confluent) human CCL 13 cells. Forty-eight hours later when the cultures were confluent, gene expression was assessed histochemically by staining with X-gal (see Materials and methods). Experiments were repeated on more than one occasion and the mean result of numbers of microscopically observed blue cells is given in Figure 4a . Consistent augmentation of pseudofection was seen when DNApseudocapsid pre-formed complexes were condensed with 0.2 g/l polylysine. Higher concentrations of polylysine enhanced expression with naked DNA, but proved toxic for cells treated with DNA-pseudocapsid complexes. Based on these data, a polylysine concentration of 0.2 g/l was taken to be optimum and was subsequently used in pseudofection reactions. Ca 2+ is required for self-assembly and maintenance of VP1 pseudocapsids and plays an important role in assembly, stability and disassembly of the outer capsid during the polyomavirus life cycle, 17 affecting the ability of capsids to penetrate the cell membrane. In order to find the optimal concentration of calcium ions for efficient gene transfer to CCL 13 cells using pCMV␤ DNA-pseudocapsids complexed with polylysine, pseudocapsids were isolated in buffers with differing (0 m, 5 m, 10 m, 50 m and 100 m) concentrations. In the presence of polylysine, DNA complexed with capsids in low Ca 2+ buffer showed significantly increased levels of gene transfer ( Figure 4b ). Consistent enhancement of gene transfer was observed with pseudocapsids prepared in a buffer containing 10 m Ca
2+
, as used in subsequent work.
Persistence of ␤-galactosidase gene expression in vitro
Having determined some of the parameters for optimising transient pseudofection efficiencies, at least for pCMV␤ DNA, persistence of ␤-galactosidase activity was examined in cells transduced with various preparations of complexes. Cultures of CCL 13 cells were pseudofected with DNA-pseudocapsid complexes, with or without polylysine, or, as control, transfected with DNA mixed with polylysine. Pseudofected cells were maintained up to 21 days (by subculturing at a 1:5 dilution every 3 days). Samples were taken at 2, 5, 11, 14 and 21 days, and stained for ␤-galactosidase expression with X-gal. At 2 days, before subculturing, the number of blue staining cells observed with DNA-polylysine or DNA-pseudocapsid complexes in the presence of polylysine averaged between 1600 and 1900 per well, respectively. This number was diminished after 5 days to between 200 and 400 per well. Only a few stained cells were observed after 11 days, and none after 14 (or 21) days (data not shown). With the relatively insensitive histochemical assay, it was not obvious that long-term expression of large DNAs, in cells that require extensive recycling, occurred by any of the chosen routes.
The expression of ␤-galactosidase in rat 2 cells, which remain viable for a relatively long period in static culture, was similarly tested, and blue cells (diminishing in number) were observed on days 2, 14 and 21 following either pseudofection or transfection of DNA in the presence of calcium phosphate. Quantification of data proved difficult in these cells, however, as expression of the endogenous enzyme resulted in high background staining, using a number of detection protocols.As an alternative assay, expression of ␤-galactosidase was evaluated at the mRNA level by the reverse transcription-polymerase chain reaction (RT-PCR) using oligonucleotide primers for the bacterial ␤-galactosidase gene. Data are given in Figure 5a . Expression over time in equal aliquots of total cellular RNAs purified from rat 2 cells treated with DNA-pseudocapsid complexes in the absence (lanes [11] [12] [13] or presence (lanes 14-16) of polylysine was assessed, alongside that of cells treated with DNA alone in the presence (lanes [17] [18] [19] or absence (lanes 8-10) of polylysine, or with calcium phosphate precipitates (lanes 20- 22) , as controls. Levels of expression from the endogenous ␤-galactosidase gene are shown (lanes 5-7). Serial dilutions of pCMV␤ (10 4 , 10 3 and 10 2 copies) were amplified using the same PCR conditions (lanes 1-3) . Track 4 contains a control where no DNA was added to the PCR reaction. Treatment of cells with DNA-pseudocapsids (pcaps) only resulted in moderate expression of RNA from the input ␤-galactosidase gene immediately following pseudofection, with expression declining to a lower, but seemingly stable, level with time (lanes 11-13). Addition of polylysine (pLK) augmented the initial levels of the ␤-galactosidase transcript (compare, for example, lane 14 with 11), in a manner that also decreased in intensity with time (lanes 14-16), the long-term (21 day) effect being similar to that seen with pseudocapsids in the absence of polylysine (compare lanes 16 and 13). When polylysine alone, or calcium phosphate, were used as transfection agents (lanes 17-19 and 20-22, respectively), a much higher initial level of transcription was achieved, but this rapidly declined, not appearing, particularly in the latter, to reach a steady state by 21 days. These data are consistent with previous in vitro experiments where pseudocapsids were seen to support long-term, stable expression. 10 To examine this supposition further, these data were analysed as shown in Figure 5b . Here (see Figure 5a) , the signal intensity at 2 days was defined as 100% and subsequent signals (14 and 21 days, respectively) were compared with the measured intensity at this time. The data obtained, from an 18 h exposure (for lanes [11] [12] [13] [14] [15] [16] [17] [18] [19] and a shorter (4 h) exposure for lanes 1-3 and 20-22, are consistent with the notion that a pseudocapsid route of delivery might have advantages for longer term gene expression, not observed with, for example, DNA transfections, with or without polylysine.
Persistence of ␤-galactosidase gene expression in vivo As discussed previously, maintaining long-term tissue cultures (without sub-culturing) was only possible with certain types of cells, making it difficult to assess, by this route, 'long-term' gene expression. We also queried whether proteinaceous matrices, which allow cells to adhere to plastic, might influence data obtained in in vitro experiments with pseudocapsids. To circumvent problems such as these, in vivo experiments were carried out in mice to assess the effects of polylysine on pseudofection. Pseudocapsid-DNA complexes, in the presence and absence of polylysine, using the 7.2 kbp pCMV␤ DNA as reporter gene (or as controls, naked DNA with or without polylysine) were injected subcutaneously into nude mice. In a preliminary experiment, tissues were collected at 1 and 7 weeks after single injections into mice and expression of the ␤-galactosidase gene was assessed histochemically. The data are summarised in Table 1 , where 'high', 'intermediate' and 'low' expression are defined as detection of Ͼ20, 20-2 or Ͻ2 (or no) positively stained areas per tissue. In the animals, at 1 week, high level expression of the ␤-galactosidase gene was observed in the spleen of animals in all experiments except when DNA only was used. In the presence of polylysine, kidney and brain of mice injected with DNA with or without pseudocapsids also showed high level expression. Skin from the animal injected with the triple complex (DNA- 
copies, respectively) using the same PCR conditions, and lane 4 contains a PCR reaction where no template DNA was added. (b) Comparative results on levels of transient (2 days) versus longer term (14, 21 days) transcriptional expression of the ␤-galactosidase gene under different conditions (described in a). Levels of expression within a particular experiment are compared with that obtained at 2 days, taken as 100%. In all cases, the levels diminish with time, but less so in the cases of DNA-pseudocomplexes (with or without polylysine) suggesting that stable levels of expression are being reached in these experiments.
pcaps + pLK) showed strong gene expression at the site of injection.
Seven weeks after injection, as in the longer term in vitro experiments, the expression pattern had changed. Expression encompassing the whole organ (high level) was seen in the heart with a mouse injected with DNApseudocapsid complexes, and intermediate expression (foci) was found in spleen, kidney and brain, without polylysine. The addition of polylysine resulted in loss of expression in brain with DNA-pseudocapsid complexes. Most gene expression had been lost from these organs in mice injected with DNA or DNA+ polylysine complexes only, although in the latter, a small amount of expression in the parotid glands and lungs was evident. These results support the suggestion that VP1 pseudocapsid complexes favour long-term expression in vivo as well as in vitro and that the major advantages seen with polylysine are probably in shorter term expression and in altering the organs targeted. Discussion VP1, derived from baculovirus, has the ability to selfassemble and can bind exogenous DNA in a cell-free system. In earlier experiments, it appeared that about 3 kbp of exogenous 'naked' DNA could be packaged with VP1 pseudocapsids and protected from DNaseI activity. 10 In the present studies, poly-l-lysine (polylysine), widely used for receptor-mediated gene transfer, 12, [14] [15] [16] was added to protect DNA that was not incorporated in the pseudocapsid complexes, to facilitate gene transfer; this reagent improved the levels of protected DNA when greater than polyoma genome-sized material was used (see Figure 1) . When exploring effects of the temporal order on creating complexes, polylysine mixed first with DNA, then added to pseudocapsids, was found to result in large aggregates (Figure 2d ). Electronmicroscopy data (Figure 3 ) suggest that polylysine not only condenses 'naked' DNA but also DNA-pseudocapsid complexes. a Analysis of the effectiveness of the VP1 pseudocapsid route using DNA-pseudocapsid complexes, in the presence or absence of polylysine, with the 7.2 kbp pCMV␤ reporter gene. Complexes, as well as 'naked' DNA, were injected into nude mice subcutaneously and tissues were collected at 1 and 7 weeks after injection. Expression of the ␤-galactosidase gene was assessed by a histochemical assay. Subsequent experiments, therefore, used a protocol involving initial mixing of DNA and pseudocapsids, followed by polylysine addition, to avoid such aggregates. To optimise the procedure, varying concentrations of Ca 2+ or polylysine were assessed. DNA-capsid-polylysine complexes gave best expression of the ␤-galactosidase gene in vitro using 0.2 g/l of polylysine during complex formation; DNA-polylysine complexes alone performed best with higher concentrations. For Ca 2+ , which plays a critical role in viral capsid assembly, disassembly and penetration of cell membranes, 17 ,18 a concentration of 10 m proved optimal ( Figure 4b) ; interestingly, this is the concentration in buffers used for purification of genuine polyoma capsids and virions. 19 Since sustained long-term expression is a desirable component of gene therapy, 1 we attempted to assess this property in tissue culture, monitoring ␤-galactosidase gene expression from a 7.2 kbp recombinant DNA in CCL 13 human liver cells, adopting various modes for gene delivery. The data obtained were consistent with a level of gene expression that, in the short term, was enhanced in the presence of polylysine, but gradually declined on continuous culture (with or without pseudocapsids) below histochemically detectable levels. To examine the possibility that pseudocapsids require time to achieve efficient gene delivery, rat 2 cells, which do not need subculturing to survive for about 3 weeks, were assessed by the same experimental routes used for CCL 13 cells, measuring transcriptional expression by RT-PCR (Figure 5a) . In vitro studies all pointed to similar conclusions. That is, whereas DNA-polylysine complexes on their own were adequate for transient gene expression, the levels of expression were unstable, as others have found, 12, 14 and by 21 days were still declining. When pseudocapsids were present, there was less distinction between the 14 and 21 day experiments. The same was true for pseudofection experiments, although here the short-term transcriptional expression was below that seen in the presence of polylysine. These data are further compared in Figure 5b giving the expression value at 2 days, within a single experiment, as 100%. The results point to cooperative effects between pseudocapsids and polylysine, and indicate that with our present protocol, polylysine enhances short-term expression, whereas pseudocapsids alone have advantages for long-term, sustained expression.
To explore this topic further, we turned to animal experiments, where time would not present the constraints experienced with cells in tissue culture. Complexes, made as defined for the in vitro culture work, were injected subcutaneously into mice and the results were investigated at 1 week (as representing short-term expression) and 7 weeks (for long-term expression). Data from preliminary experiments on single mice (subsequently confirmed for DNA and DNA-pseudocapsid complexes in a larger scale study, over 3 months) are given in Table l . Here, we found that at 1 week, generally similar results were obtained in the polylysine experiments, with or without pseudocapsids, with highest levels of expression being observed in spleen, kidney and brain. In the presence of pseudocapsids, without polylysine, targeting was mainly to the spleen. With DNA alone, the overall expression levels in all organs were lower, and with this route, by 7 weeks no expression was observed. At this time, with DNA-polylysine complexes, the levels of expression had also declined. With DNApseudocapsid complexes, on the other hand, expression levels were sustained or even increased, a number of organs having been stably targeted including, unexpectedly, the brain. Interestingly, polylysine appears to allow targeting to the parotid gland, not seen with DNApseudocapsids on their own, a result that requires further exploration. The lack of efficiency in the early stages of delivery by pseudocapsids appears to be compensated for later, presumably by stable integration into the host chromosome. In future experiments we will be examining this question, seeking an answer to the time requirement seen with pseudocapsids.
Gene transfer using pseudocapsids resembles nonviral gene transfer systems in that none of the viral genome is present. Our experiments were designed to study the role of polylysine in assisting gene transfer of high molecular weight DNA, having assumed that it (or a similar chemical agent) would be required to protect DNAs larger in size than those that could be encompassed within the pseudocapsids alone (that is, about 3 kbp). Our current experiments show that this is not the case, and that VP1 pseudocapids on their own can deliver a gene so as to produce sustained expression both in vitro and in vivo, encoded in larger plasmids, such as the 7.2 kbp DNA used in most of our assays. (We have preliminary data that expression with plasmids larger than 10 kbp in size can also be achieved by this route; unpublished observations.) Although polylysine was effective in increasing transient expression of an input reporter gene, it provided little apparent value in experiments aimed at long-term persistent expression. However, its use may be advantageous in directing the gene to a particular organ or cell type (see Table 1 ), and in situations where levels, rather than duration, of gene expression are of prime importance.
Materials and methods
Cells ATCC CCL 13 cells, a human liver-derived cell line, and rat 2 cells, an immortal rat fibroblast line, were passaged in complete Dulbecco's modified Eagle's medium (DMEM) containing 10% foetal calf serum (FCS) and 2 mm glutamine.
Purification of polyoma virus empty pseudocapsids
Spodoptera frugiperda (Sf9) insect cells were grown either as a monolayer or in stirrer culture at 27°C in Graces insect medium containing 10% FCS. The culture was infected with VL-VP1 recombinant baculovirus at 2 p.f.u. per cell at 27°C for 96 h after infection. 20 Infected cells were pelleted and resuspended in Buffer A (150 mm NaCl, 10 mm Tris-HCl, pH 7.6, 0.01 mm CaCl 2 , 5% glycerol and 0.01% Triton-X 100 (v/v)), and disrupted by sonication (15 microns amplitude for 10 s) using an MSE Soniprep 150 (MSE; Manor Royal, UK). Cell debris and unbroken nuclei were pelleted by low-speed centrifugation. Pellets were resuspended in Buffer A and resonicated. The supernatants were pooled, and particles pelleted by centrifugation through a 20% sucrose cushion (w/v), resuspended in Buffer B (150 mm NaCl, 10 mm Tris-HCl, pH 7.6, 0.01 mm CaCl 2 , 0.01% Triton-X 100), and centrifuged to equilibrium in a CsCl gradient (refractive index 1.40) for 48 h at 160 000 g in a Beckman SW-41 (Beckman, High Wycombe, UK) rotor to give two distinct bands of VP1-containing material, the major product, with a buoyant density 1.283-1.294 g/cm 3 , consisting of empty particles, and the other, at 1.315-1.348 g/cm 3 representing full pseudocapsids, containing some packaged host cell and baculoviral DNA.
11 Empty capsids were concentrated by centrifugation through a 20% sucrose cushion and resuspended in a small volume (0.5 ml) of Buffer B containing 30% glycerol. Total protein was measured using the bicinchoninic acid method (Sigma, Poole, UK).
Buffers A and B, containing 0 m, 1 m, 10 m, 50 m and 100 m CaCl 2 , were used for purification and storage of empty polyoma pseudocapsids, in experiments aimed at optimising the concentration of CaCl 2 needed for optimal pseudocapsid-mediated gene transfer.
DNA pCMV␤ (Clontech, Palo Alto, CA, USA) DNA containing the bacterial ␤-galactosidase gene under the control of the CMV early promoter and enhancer was used for assessing the efficiency of gene transfer and analysing the interactions between DNA, pseudocapsids and polylysine.
DNA packaging and pseudofection with pseudocapsids DNA was packaged into pseudocapsids according to the procedure of Barr et al. 21 For in vitro packaging, approximately 1 g of circular or linear DNA, containing the reporter gene, was mixed with 30 g of pseudocapsids and incubated at 37°C for 10 min. The mixture was exposed to osmotic shock by dilution with four volumes of H 2 O. In experiments where poly-l-lysine (Sigma; molecular weight 30 000-70 000) was used as a means of condensing DNA, 2 g of this reagent was added to the DNA-pseudocapsid mixture before osmotic shock; the reaction was incubated at 37°C for a further 10 min, then added to cells. With CCL 13 cells, half confluent cultures (4 × 10 5 cells) were incubated for 90 min with occasional rocking, then excess DMEM medium supplemented with 10% FCS was added. For rat 2 cells, half confluent cultures were also used for pseudofection.
Protection of exogenous DNA against DNaseI activity with polylysine pCMV␤ DNA (1 g) was used for assessing the protection of unencapsidated material from DNaseI digestion in the presence or absence of polylysine and pseudocapsids in vitro. Following a packaging step, 10 0.11 U pancre- P-labelled according to the instructions of the multiprime DNA labelling kit (Amersham International, Bucks, UK). Membranes were exposed to radiographic film (XAR-5, Kodak, Rochester, NY, USA) for 20 min at room temperature, and the resulting hybridisation signals analysed by densitometry.
Histochemical staining for ␤-galactosidase activity in cells Cells transfected in culture with combinations of DNA and pseudocapsids, with or without polylysine, were washed with phosphate-buffered saline (PBS) and fixed in 0.1% glutaraldehyde in PBS for 10 min at room temperature, then washed twice in PBS, and incubated in Xgal solution (5 mm K 3 Fe(CN) 6 , 5 mm K 4 Fe(CN) 6 и3H 2 O, 2 mm MgCl 2 , 0.4 mg/ml 5-bromo-4-chloro-indolyl-␤-dgalactopyranoside (X-gal); Promega, Madison, WI, USA) in PBS for 20-24 h at room temperature. Expression of the ␤-galactosidase gene product in cells was detected by an indigo blue colour seen on examination by light microscopy.
Staining for ␤-galactosidase activity in whole tissues Whole tissues from nude mice previously treated subcutaneously with either 'naked' pCMV␤ DNA, or complexes with or without polylysine and pseudocapsids, immediately following dissection, were washed in PBS and fixed with a solution consisting of 1% formaldehyde, 0.2% glutaraldehyde, 2 mm MgCl 2 , 5 mm EGTA and 0.02% NP-40. Excess fixative was removed after 1 h by washing in PBS, and the sample was incubated overnight in the dark with staining reagents (5 mm K 3 Fe(CN) 6 , 5 mm K 4 Fe(CN) 6 и3H 2 O, 2 mm MgCl 2 , 0.02% NP-40, 1 mg/ml X-gal in PBS). All procedures were carried out at room temperature. Samples were examined by low power light microscopy and areas of blue stain scored in whole tissues; alteratively for confirmation, sections (1-2 mm) were excised from areas of stained tissue and observed at high magnification.
RNA isolation and RT-PCR assays
Total RNA was isolated from either a transfected or pseudofected (with pseudocapsids) mammalian cell culture (of rat 2 cells) using an RNA extraction kit (Qiagen, West Sussex, UK) then treated with DNaseI to remove any remaining DNA. Synthesis of cDNA from 2 g total RNA was performed using an oligonucleotide reverse primer (5Ј-TTCCAGATAACTGCCGTCACTCC) (250 nm). To inactivate reverse transcriptase and denature the RNA-cDNA hybrids, samples synthesised from 1 g RNA in each case were incubated at 96°C for 5 min. PCR was carried out with 100 nm oligonucleotide primer (5Ј-GGCATTGGTCTGGACACCAGCA) and the same concentration of reverse primer in a thermal cycler (Hybaid, Teddington, UK) using a programme consisting of one cycle of 5 min at 94°C, 45 s at 60°C and 2 min at 72°C, followed by 30 cycles of 45 s at 94°C, 45 s at 60°C and 2 min at 72°C. One final cycle of 10 min at 72°C completed the reaction. PCR products were analysed by electrophoresis in a 1.0% agarose gel and the products were transferred on to a Biodyn B transfer membrane (Pall) and hybridised with a 32 P-labelled pCMV␤ DNA probe (see above).
Product quantities were determined by densitometry. Band densities were calculated using as standards bands those obtained from amplified pCMV␤ (the signals of 10 4 , 10 3 and 10 2 amplified copies of this DNA given values of 10 000, 1000 and 100, respectively) using a Kodak Digital Science programme (Kodak Scientific Imaging Systems, Rochester, NY, USA).
